Expenditure breakdown | r = 0% | r = 2.5% | r = 5% |
---|---|---|---|
Expenditures to allocate per activity | |||
Planning, management, overhead | 23,344,310.3 (9.9%) | 22,354,500.5 (9.9%) | 21,452,393.7 (9.9%) |
Human resources | 18,832,191.0 (7.9%) | 17,908,566.6 (7.9%) | 17,073,288.8 (7.9%) |
Training | 24,079,991.4 (10.2%) | 23,069,448.3 (10.2%) | 22,140,357.8 (10.2%) |
Monitoring and evaluation | 13,20,0.902.1 (5.6%) | 12,564,534.9 (5.6%) | 11,986,597.2 (5.6%) |
Supply management | 7,680,371.2 (3.2%) | 7,199,310.1 (3.2%) | 6,762,849.9 (3.2%) |
Infrastructure and equipment | 12,228,240.7 (5.2%) | 11,796,917.8 (5.2%) | 11,397,866.8 (5.2%) |
Other | 6,756,056.6 (2.9%) | 6,448,811.4 (2.9%) | 6,170,403.7 (2.9%) |
Total of common costs* | 106,119,063.4 (44.6%) | 101,342,089.6 (44.6%) | 96,983,757.8 (44.6%) |
Preventive strategies | Â | Â | Â |
ITNs (nets) | 63,687,643.1 (27.0%) | 60,885,897.8 (27.0%) | 58,345,090.2 (27.0%) |
IRS (insecticides and spray equipment) | 40,026,935.9 (17.1%) | 38,696,527.1 (17.1%) | 37,470,203.6 (17.1%) |
Communication and advocacy | 7,429,787.7 (3.1%) | 7,077,639.1 (3.1%) | 6,755,555.9 (3.1%) |
Total | 111,144,366.7 (46.8%) | 106,660,064.0 (46.9%) | 102,570,849.7 (46.9%) |
Treatment strategy | Â | Â | Â |
Diagnostic tests: mRDTs, microscopy | 10,318,495.8 (4.4%) | 9,638,662.99 (4.3%) | 9,026,723.9 (4.3%) |
Antimalarial medicines | 9,991,983.0 (4.2%) | 9,514,573.83 (4.2%) | 9,076,804.4 (4.2%) |
Total | 20,310,478.8 (8.5%) | 19,153,236.8 (8.5%) | 18,103,528.3 (8.5%) |
Total cost | 237,573,908.8 (100%) | 227,155,390.4 (100%) | 217,658,135.9 (100%) |